Commission Delegated Regulation (EU) 2021/1760 of 26 May 2021 supplementing Regulation (EU) 2019/6 of the European Parliament and of the Council by establishing the criteria for the designation of antimicrobials to be reserved for the treatment of certain infections in humans (Text with EEA relevance)

CELEX: 32021R1760
Document type: REG_DEL
Sector: Legislation
Date of document: 2021-05-26
In force since: 2021-10-26
Status: In force
ELI: http://data.europa.eu/eli/reg_del/2021/1760/oj

Text

Article-level text, parsed from the formex manifestation.

Article 1

1 The criteria for the designation of antimicrobials to be reserved for the treatment of certain infections in humans are set out in the Annex.

2 An antimicrobial or a group of antimicrobials shall meet all three criteria set out in Parts A, B and C in the Annex in order to be designated as reserved for treatment of certain infections in humans.

Article 2

This Regulation shall enter into force on the twentieth day following that of its publication in the Official Journal of the European Union. It shall apply from 28 January 2022.

Relations

What this act cites, and what cites it.

Show relations

Versions

Point-in-time consolidated versions of this act.

Show versions